Document is current
Any future updates will be listed below
-
Authors
Wenzel, Mike
Filzmayer, Maximilian
Siech, Carolin
Le, Quynh Chi
Lauer, Benedikt
Theissen, Lena
Hoeh, Benedikt
Heinzer, Hans
Graefen, Markus
Steuber, Thomas
Kriegmair, Maximilian
Chun, Felix K.-H.
Mandel, Philipp
-
Funding
Funding for this research was provided by:
Johann Wolfgang Goethe-Universität, Frankfurt am Main
- License Information
-
More Information
Article History
Received: 13 August 2025
Accepted: 24 February 2026
First Online: 2 March 2026
Declarations
:
: The current study was in accordance with the Declaration of Helsinki. Review of the local ethics board was approved (“Ethikkommission des Fachbereichs Medizin Universitätsklinikum der Goethe-Universität”, reference number: SUG-5-2024). Given theor individual patient consent was waived.
: Not applicable. The study does not include identifiable individual data.
: MW received speaker honoraria or is consultant for Accord, Astellas, Johnson & Johnson, Pfizer, MSD, Astra Zeneca, Ipsen and Bayer. MF received speaker honoraria or is consultant for Johnson & Johnson and Bayer. CS received speaker honoraria or is consultant for Johnson & Johnson and Merck KGaA. BH received speaker honoraria or is consultant for Johnson & Johnson and Ipsen. TS received speaker honoraria or is consultant for AMGEN, Astellas, Astellas, Astra Zeneca, Bayer, Johnson & Johnson, MSD, Novartis, Novartis, Pfizer, Proteomedics and Sanofi. FC received speaker honoraria or is consultant for Astellas, AstraZeneca, Bayer, Johnson & Johnson, Lumenis, Novartis, Molecular Health, Olympusa and Pfizer. PM received speaker honoraria or is consultant for AMGEN, Astellas, AstraZeneca, Bayer, IPSEN, Johnson & Johnson, MSD, Novartis, Orion and Pfizer. The other authors declare that they have no competing interests.
